Expression Patterns of CD44 and AREG Under Treatment With Selective Tyrosine Kinase Inhibitors in HPV+ and HPV− Squamous Cell Carcinoma

Cancer Genomics & Proteomics ◽

10.21873/cgp.20214 ◽

2020 ◽

Vol 17 (5) ◽

pp. 579-585

Author(s):

BENJAMIN KANSY ◽

CHRISTOPH ADERHOLD ◽

LENA HUBER ◽

SONJA LUDWIG ◽

RICHARD BIRK ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Expression Patterns

Download Full-text

Tyrosine kinase inhibitors in head and neck squamous cell carcinoma – a therapeutic chance?

10.1055/s-0041-1727986 ◽

2021 ◽

Author(s):

A Lammert ◽

A Affolter ◽

J Heid ◽

Y Jakob ◽

F Jungbauer ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Head And Neck ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Neck Squamous Cell Carcinoma

Download Full-text

The effect of selective tyrosine kinase inhibitors on the expression of HIF1α and mTOR in p16-positive and -negative squamous cell carcinoma (HNSCC)

10.1055/s-0038-1640071 ◽

2018 ◽

Author(s):

B Kramer ◽

B Kuhlin ◽

N Rotter ◽

C Aderhold

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors

Download Full-text

EGFR tyrosine kinase inhibitors differentially affect autophagy in head and neck squamous cell carcinoma

Biochemical and Biophysical Research Communications ◽

10.1016/j.bbrc.2017.03.157 ◽

2017 ◽

Vol 486 (4) ◽

pp. 1027-1033 ◽

Author(s):

Jinyang Cai ◽

Ming Sun ◽

Xin Ge ◽

Yue Sun

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Head And Neck ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Neck Squamous Cell Carcinoma ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

371: Esophageal squamous cell carcinoma cells stimulate the formation of a hyaluronan-rich microenvironment: implications for fibroblast phenotype and sensitivity to tyrosine kinase inhibitors

European Journal of Cancer ◽

10.1016/s0959-8049(14)50331-0 ◽

2014 ◽

Vol 50 ◽

pp. S89

Author(s):

I. Kretschmer ◽

T. Freudenberger ◽

S. Twarock ◽

J.W. Fischer

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Carcinoma Cells

Download Full-text

Tyrosine Kinase Inhibitors and Everolimus Reduce IGF1R Expression in HPV16-positive and -negative Squamous Cell Carcinoma

Anticancer Research ◽

10.21873/anticanres.14374 ◽

2020 ◽

Vol 40 (7) ◽

pp. 3847-3855

Author(s):

BENDIKT KRAMER ◽

ANGELA SCHELL ◽

CHRISTOPH ADERHOLD ◽

LENA HUBER ◽

C. EMIKA MUELLER ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Igf1r Expression

Download Full-text

Consecutive Emergence of Typical Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in a Patient With Metastatic Pulmonary Squamous Cell Carcinoma

Journal of Oncology Practice ◽

10.1200/jop.18.00536 ◽

2019 ◽

Vol 15 (2) ◽

pp. 115-118 ◽

Author(s):

Ching-Yao Yang ◽

Min-Shu Hsieh ◽

Wei-Yu Liao ◽

Jin-Yuan Shih ◽

Chong-Jen Yu

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case

Lung Cancer ◽

10.1016/j.lungcan.2018.11.016 ◽

2019 ◽

Vol 127 ◽

pp. 12-18 ◽

Author(s):

Elisa Roca ◽

Marta Pozzari ◽

William Vermi ◽

Valeria Tovazzi ◽

Alice Baggi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Pooled Analysis ◽

Additional Case ◽

Nsclc Patients ◽

Download Full-text

mTOR- and tyrosine kinase inhibitors reduce AKT- and IGF-R expression in squamous cell carcinoma (HNSCC), dependent on p16 status

10.1055/s-0038-1640075 ◽

2018 ◽

Author(s):

B Kuhlin ◽

B Kramer ◽

N Rotter ◽

C Aderhold

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors

Download Full-text

The effect of selective tyrosine kinase inhibitors on the expression of CD44 and AREG in HPV-positive and -negative squamous cell carcinoma

10.1055/s-0039-1686014 ◽

2019 ◽

Author(s):

B Kramer ◽

M Kneissle ◽

N Rotter ◽

C Aderhold

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors

Download Full-text

Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma

Medical Oncology ◽

10.1007/s12032-017-0918-1 ◽

2017 ◽

Vol 34 (4) ◽

Author(s):

Wiktoria Blaszczak ◽

Wojciech Barczak ◽

Anna Wegner ◽

Wojciech Golusinski ◽

Wiktoria Maria Suchorska

Keyword(s):

Squamous Cell Carcinoma ◽

Monoclonal Antibodies ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Head And Neck ◽

Tyrosine Kinase Inhibitors ◽

Squamous Cell ◽

Kinase Inhibitors ◽

Neck Squamous Cell Carcinoma ◽

Download Full-text